Article

Mentholated Cigarettes No More Harmful Than Regular Cigarettes

Author(s):

Contrary to the conventional wisdom, mentholated cigarette smokers are less likely to develop lung cancer

Contrary to the conventional wisdom, mentholated cigarette smokers are less likely to develop and then die from lung cancer than those who smoke nonmentholated cigarettes.

Nearly 86,000 people from 12 southern states were enrolled into the multiracial Southern Community Cohort Study. Because blacks—who smoke mentholated cigarettes more than whites—have higher lung cancer rates than whites, many assumed that menthol was the reason for the increase in lung cancer rates among blacks. Menthol is a crystalline alcohol that occurs in mint oils and causes a cooling effect. Some studies had previously indicated that menthol affects the lung’s biology or that mentholated cigarettes compel smokers to inhale the smoke more deeply into the lungs. As a result, many thought that adding menthol to cigarettes would make quitting smoking even more difficult.

The Southern Community Cohort Study led by William J. Blot, PhD, of the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee compared 440 patients with lung cancer with 2213 matched controls who had the same demographics but no lung cancer.

Blot and colleagues determined that mentholated cigarettes were associated with a statistically significant lower incidence of lung cancer than regular cigarettes. In those smoking ≥20 cigarettes per day, smokers of nonmentholated cigarettes were 21 times more likely to have lung cancer whereas smokers of mentholated cigarettes were 12 times as likely to have the disease.

Interestingly, the study found that mentholated cigarette smokers—both black and white—reported smoking fewer cigarettes per day than nonmentholated cigarette smokers.

The study did not determine, however, why blacks have a higher incidence of lung cancer than whites.

Source: Blot WJ, International Epidemiology Institute, et al. Lung cancer study finds mentholated cigarettes no more harmful than regular cigarettes. J Natl Cancer Inst. 2011:doi:10.1093/jnci/djr126.

Related Videos
Julia Rotow, MD, clinical director, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute; assistant professor, medicine, Harvard Medical School
Joshua K. Sabari, MD, assistant professor, Department of Medicine, New York University Grossman School of Medicine; director, High Reliability Organization Initiatives, Perlmutter Cancer Center
Leah Backhus, MD, MPH, FACS, professor, University Medical Line, Cardiothoracic Surgery, co-director, Thoracic Surgery Clinical Research Program, associate program director, Thoracic Track, CT Surgery Residency Training Program, Thelma and Henry Doelger Professor of Cardiovascular Surgery, Stanford Medicine; chief, Thoracic Surgery, VA Palo Alto
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Medical Oncology, director, Center for Thoracic Cancers, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine
A panel of 4 experts on lung cancer
A panel of 4 experts on lung cancer
5 KOLs are featured in this peer exchange
5 KOLs are featured in this peer exchange
4 KOLs are featured in this series
4 KOLs are featured in this series